E12: GDPR Article 22 and Automated Decision Making
Deloitte: Turnarounds and Democracy Don't Mix
Bricker Graydon’s Higher Education Fall 2024 Title IX Trainings - As the landscape of Title IX continues to evolve, it's essential for educational institutions to stay ahead of the curve. Our Fall 2024 Title IX Trainings...more
As a business advisor, understanding the succession process for business owners can significantly benefit your ability to attract and build a business owner practice successfully. Long-term thinking can be complex for some...more
September 2024 K-12 Education Title IX Regulations Training Series - Bricker Graydon’s K-12 Education Team is pleased to announce a September 2024 series of trainings to learn how to remain compliant with the 2020 Title...more
Coordination between the Owner-Architect Agreement and the Owner-Contractor Agreement is crucial for any successful project. In particular, parties most commonly overlook the provisions related to an Initial Decision Maker...more
Watching the Olympics has been a thrilling ride, with jaw-dropping athletic feats and heartwarming displays of sportsmanship. But amidst this celebration of human excellence, the barrage of AI ads has been a mixed bag. While...more
In a landmark move on 27 December 2023 the Bermuda Government took a significant step by adopting the Corporate Income Tax Act 2023 (the “CIT Act”), a pivotal piece of legislation that promises to reshape the island’s...more
Bricker Graydon’s K-12 Education Team is pleased to announce a Fall 2024 series of trainings to learn how to remain compliant with the 2020 Title IX regulations. Because in Ohio (where most of our attendees are operating),...more
Under the Chevron doctrine, FDA and other agencies had significant flexibility to set policy where Congress left a gap or failed to speak clearly when enacting legislation—a common occurrence given the at-times sparse...more
The US Patent & Trademark Office (PTO) announced a final rule concerning pre-issuance internal circulation and review of decisions within the Patent Trial & Appeal Board. The new rules are designed to bolster the independence...more
In an article last year, we discussed the increased pressure companies face to separate businesses that are not deemed “core,” and why tax-free spin-offs and similar transactions may be the most appealing way to achieve this....more
Victory at any cost can sometimes be more damaging than defeat itself. This principle is embodied in the concept of a Pyrrhic victory—where a victory inflicts such a devastating toll on the victor that it is tantamount to...more
Last week, the Department of Health and Human Services (HHS) finalized antidiscrimination regulations implementing Section 1557 of the Affordable Care Act (ACA Section 1557). The final rule expands upon the proposed rule’s...more
On April 15, 2024, the US Food & Drug Administration (FDA) announced the establishment of the Center for Drug Evaluation and Research (CDER) Center for Clinical Trial Innovation (C3TI). C3TI will serve as the central support...more
For the first time in nearly 15 years, the U.S. Patent and Trademark Office (USPTO) has issued “Updated Guidance for Making a Proper Determination of Obviousness” under the U.S. Supreme Court’s ruling in KSR Int’l Co. v....more